Over the past five years, federal stimulus spending has been the primary source of funding for the Scientific Research and Development industry. Industry operators largely rely on government funding to provide research activities, but private investment has become increasingly crucial in recent years. Government consumption and investment rose to its highest point in 2010; however, more recently these levels have fallen away as austerity measures and budget sequestration shrink potential budget allocations. In the coming years, the industry is expected to maintain growth as industry revenue accelerates due to stronger private spending. However, over the short term, revenue growth is expected to be slow as federal funding remains weak, especially for defense programs that generate demand for research and development.
This industry includes companies and organizations that are involved in physical, engineering or life sciences research and development (R&D). The industry only includes operators whose primary purpose is R&D and excludes players such as pharmaceutical or manufacturing companies that may undertake R&D to support their primary operations. Government entities are also excluded from this industry, though these entities may contract and fund the research this industry undertakes.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.